-
The incidence, predictors, and outcomes of delirium in Parkinson’s disease and atypical parkinsonism
-
The Indian Experience of Continuous Dopaminergic therapy with Apomorphine in Parkinson’s Disease
-
The Influence of 3-Phenoxybenzoic Acid in Dopaminergic Degeneration
-
The influence of ANNK1/DRD2 haplotypes on the onset of complications of long-term levodopa therapy in Parkinson’s disease
-
The interaction of Parkin and TAF15 for the Drosophila in which neuronal defect was induced
-
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset
-
The Levodopa in Early Parkinson’s disease (LEAP) study: Post-hoc analyses
-
The Many Faces of Bradykinesia in Parkinson’s Disease : The Quantitative Analysis from A Keyboard Typing Test
-
The non-declaration of musculoskeletal pain in Parkinson’s disease in patient-related outcome measures –The King’s experience
-
The pathophysiology of dystonic tremors and comparison with essential tremor
- « Previous Page
- 1
- …
- 133
- 134
- 135
- 136
- 137
- …
- 149
- Next Page »